Top Clinical Trials companies in Europe by EBIT

This ranking features the top 269 Clinical Trials companies in Europe ranked by EBIT, totaling a EBIT of USD 99.15 B, for June 30, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2 3 4 5 6

Frequently Asked Questions

Which Clinical Trials company in Europe has the highest EBIT ?

The Clinical Trials company in Europe with the highest EBIT is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 17.87 B.
Which Clinical Trials company in Europe has the lowest EBIT ?

The Clinical Trials company in Europe with the lowest EBIT is Aptorum Group Limited (NasdaqCM: APM) at None.

What are the top 10 Clinical Trials companies in Europe by EBIT ?

The top 10 Clinical Trials companies in Europe by EBIT are Novo Nordisk A/S, Novartis AG, Roche Holding AG, AstraZeneca PLC, Sanofi, Medtronic plc, GSK plc, Bayer AG, MERCK Kommanditgesellschaft auf Aktien and RELX Plc.
What are the bottom 10 Clinical Trials companies in Europe by EBIT ?

The bottom 10 Clinical Trials companies in Europe by EBIT are Aptorum Group Limited, Advicenne S.A., genOway SA, Akari Therapeutics, Plc, Biosynex SA, Addex Therapeutics Ltd, Affluent Medical SA, Adocia SA, 2cureX AB (publ) and Atai Life Sciences N.V..